Humana (NYSE: HUM) president exercises stock options and withholds shares for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Humana Inc. President, Insurance George Renaudin II reported option-related activity in Humana common stock. On 02/24/2026, he acquired 1,035 shares through an exercise of stock options and disposed of 419 shares at $177.075 per share to cover tax liabilities on performance stock vesting, receiving no cash value in return.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Renaudin George II
Role
President, Insurance
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Humana Common | 1,035 | $0.00 | -- |
| Tax Withholding | Humana Common | 419 | $177.075 | $74K |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Phantom Stock Units | -- | -- | -- |
| holding | Humana Common | -- | -- | -- |
Holdings After Transaction:
Humana Common — 16,494 shares (Direct);
Options — 4,162 shares (Direct);
Phantom Stock Units — 174 shares (Indirect, See Footnote);
Humana Common — 529 shares (Indirect, See Footnote)
Footnotes (1)
- Shares held for the benefit of reporting person as of January 31, 2026 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c). Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27. Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Phantom Stock Units held for the benefit of reporting person as of January 31, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. Includes Performance Stock Units not required to be reported until vesting on 2/24/26. Shares disposed of represent payment for tax liability on performance stock vesting on 2/24/26. No value was received in return.
FAQ
What did Humana (HUM) executive George Renaudin report in this Form 4?
George Renaudin reported option-related transactions in Humana common stock. He exercised stock options to acquire 1,035 shares and disposed of 419 shares to satisfy tax liabilities related to performance stock vesting, with no cash value received for the tax-withholding shares.
Was George Renaudin’s Humana Form 4 transaction an open-market buy or sale?
The filing shows an option exercise and a tax-withholding disposition, not open-market trading. Shares were acquired via stock option exercise and 419 shares were delivered back to cover tax obligations on vested performance stock, with no sale proceeds paid to the executive.
What does the Form 4 say about George Renaudin’s remaining Humana holdings?
After these transactions, Renaudin directly held 16,075 Humana common shares. The filing also notes option positions and equity awards, including 9,059 restricted stock units and performance stock units that are not required to be reported until vesting on February 24, 2026.
How are phantom stock units described in George Renaudin’s Humana filing?
Phantom stock units are held for his benefit under the Humana Retirement Equalization Plan on a 1-for-1 value basis with Humana common stock. Contributions occur annually and are reported with transaction code “J”; the ending unit balance fluctuates with changes in Humana’s stock price.